Aliquots - Research Briefs Archive — Page 35 of 87
-
January 31, 2019
New target for chronic kidney disease
Preventing the formation of secretory structures that promote scarring in the kidney could offer new therapeutic options for a disease that affects millions of people worldwide. -
January 17, 2019
Signals from the “conveyor belt”
Vanderbilt researchers propose that cellular signaling pathways are amplified by a “conveyor belt” mechanism that exchanges active and inactive enzymes. -
January 17, 2019
Pain relievers a risk for C. diff?
A link between anti-inflammatory drugs such as ibuprofen and C. diff infection suggests caution against overusing such drugs in patients at high risk for infection. -
January 17, 2019
DNA’s on/off switch
DNA-binding “switches” represent a fundamentally new method of communication between DNA-processing enzymes, Vanderbilt researchers propose. -
January 17, 2019
Building a pancreas
Vanderbilt investigators are defining the genetic programs that control the development of pancreatic beta cells — studies that could inform new cellular or regenerative therapies for diabetes. -
December 13, 2018
Lean vs. obese adipose tissue cells
A greater understanding of the mechanisms and cell types involved in returning adipose (fatty) tissue to the lean state may lead to more effective treatments for obesity. -
December 13, 2018
Breast cancer-killing RIG
A compound that activates a virus-sensing receptor has potent therapeutic effects in a mouse model of breast cancer.